- News Home
12 December 2013 1:00 pm ,
Vol. 342 ,
The iconic 125-year-old Lick Observatory on Mount Hamilton near San Jose, California, is facing the threat of closure...
Recent results from the Curiosity Mars rover have helped scientists formulate a plan for the next phase of its mission...
A new, remarkably powerful drug that cripples the hepatitis C virus (HCV) came to market last week, but it sells for $...
In pretoothbrush populations, gumlines would often be marred by a thick, visible crust of calcium phosphate, food...
Evolutionary biologists have long studied how the Mexican tetra, a drab fish that lives in rivers and creeks but has...
Victorian astronomers spent countless hours laboriously charting the positions of stars in the sky. Such sky mapping,...
In an ambitious project to study 1000 years of sickness and health, researchers are excavating the graveyard of the now...
Stefan Behnisch has won awards for designing science labs and other buildings that are smart, sustainable, and...
- 12 December 2013 1:00 pm , Vol. 342 , #6164
- About Us
European Treaty Bans Dubious Biotech Research
7 April 1997 8:00 pm
LONDON--Several European countries have agreed to the first-ever international convention on biomedical ethics. The nonbinding treaty, signed on 4 April at a ceremony in Oviedo, Spain, sets strict limits on the use of genetic engineering in medical research, and it includes a ban on research involving human embryos.
The convention, drawn up by the 40-member Council of Europe and signed by 21 European countries, aims to protect people from the misuse of biological and medical advances by establishing the first common bioethics standards. It bans the creation of human embryos for research, international trade in human organs for transplantation, and the use of in vitro fertilization to help choose a child's sex, except to avoid a "serious hereditary condition" such as hemophilia, the gene for which lies on the X chromosome. It also limits the use of genetic engineering to areas of preventative, diagnostic, or therapeutic medicine "only where it does not aim to change the genetic makeup of a person's [descendants]."
The treaty is meant to establish common standards throughout Europe so that research groups do not shift projects from one European country to another with less restrictive rules. Council officials hope the convention's principles will also be adopted outside Europe. "Today, research is a transnational activity, and Western companies can carry out research in any part of the world," says Council of Europe Secretary-General Daniel Tarschys. "That is why it is not enough for developed countries to enact laws on their own territory." Each signatory must now ratify the treaty and write implementing laws; Germany and the United Kingdom did not sign but are expected to later.